These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
967 related articles for article (PubMed ID: 9202127)
1. Structure and function of a new STAT-induced STAT inhibitor. Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127 [TBL] [Abstract][Full Text] [Related]
2. A family of cytokine-inducible inhibitors of signalling. Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125 [TBL] [Abstract][Full Text] [Related]
3. A new protein containing an SH2 domain that inhibits JAK kinases. Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126 [TBL] [Abstract][Full Text] [Related]
4. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo. Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496 [TBL] [Abstract][Full Text] [Related]
5. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666 [TBL] [Abstract][Full Text] [Related]
6. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746 [TBL] [Abstract][Full Text] [Related]
7. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Minamoto S; Ikegame K; Ueno K; Narazaki M; Naka T; Yamamoto H; Matsumoto T; Saito H; Hosoe S; Kishimoto T Biochem Biophys Res Commun; 1997 Aug; 237(1):79-83. PubMed ID: 9266833 [TBL] [Abstract][Full Text] [Related]
8. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation. Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030 [TBL] [Abstract][Full Text] [Related]
9. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487 [TBL] [Abstract][Full Text] [Related]
11. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194 [TBL] [Abstract][Full Text] [Related]
12. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex. Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006 [TBL] [Abstract][Full Text] [Related]
13. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646 [TBL] [Abstract][Full Text] [Related]
14. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. Lejeune D; Demoulin JB; Renauld JC Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404 [TBL] [Abstract][Full Text] [Related]
16. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a. Piekorz RP; Hocke GM Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012 [TBL] [Abstract][Full Text] [Related]
17. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway. Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Chen T; Wang LH; Farrar WL Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674 [TBL] [Abstract][Full Text] [Related]
20. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. Ernst M; Inglese M; Waring P; Campbell IK; Bao S; Clay FJ; Alexander WS; Wicks IP; Tarlinton DM; Novak U; Heath JK; Dunn AR J Exp Med; 2001 Jul; 194(2):189-203. PubMed ID: 11457894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]